POM-V Prescription Required

Porcilis Glässer Suspension for Injection for Pigs

Active ingredient: Haemophilus parasuis

Form

Injection

Species

Pigs

Manufacturer

Intervet International B.V.

VMD MA No.

06376/5033

What it's used for

parasuis serotype 5. Onset of immunity: 2 weeks after completion of vaccination. Duration of immunity: 14 weeks after completion of vaccination. Sows: For...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Haemophilus parasuis

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Porcilis Glässer Suspension for Injection for Pigs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

parasuis serotype 5.
Onset of immunity: 2 weeks after completion of vaccination.
Duration of immunity: 14 weeks after completion of vaccination.
Sows:
For passive immunisation of the progeny of vaccinated sows and gilts to reduce
infection, mortality, clinical signs and typical lesions of Glässer disease caused by G.
parasuis serotype 5 and to reduce clinical signs and mortality caused by
serotype 4.
Onset of immunity: After birth and sufficient uptake of colostrum.
Duration of immunity: 4 weeks of age against serotype 4 and at 6 weeks of age against
serotype 5.

Allow vaccine to reach ambient temperature. Shake well before use.
Administer 2 ml (one dose) of the vaccine intramuscularly in the neck.
Vaccination scheme pigs:
Vaccinate pigs of at least five weeks of age twice with an interval of two weeks.
Vaccination scheme sows:
Vaccinate sows at 6 to 8 weeks before expected time of farrowing twice with an interval
of four weeks.
Very common
(>1 animal / 10 animals treated):
Elevated temperature
, Lying down
, Reduced
food intake
, Decreased drinking
,
Injection site swelling
Injection site reddening
3,
Injection site warmth
3,
Injection site pain
Common
(1 to 10 animals / 100 animals
treated):
General illness
Revaccination scheme sows:
For sows vaccinated during the previous pregnancy, a single revaccination at 4 to 2
weeks before farrowing is recommended.

None.

Pigs:
Very common
(>1 animal / 10 animals treated):
Elevated temperature
, Discomfort
,
Decreased activity
, Depression
,
Injection site swelling
, Injection site
reddening
Common
(1 to 10 animals / 100 animals treated):
Vomiting
Very rare
(<1 animal / 10.000 animals treated,
including isolated reports):
Anaphylactic-type reaction
1
≤ 2 °C.
May occur on the day of vaccination. The next day returning to normal.
Painless reddish swellings of 2.5 - 7.5 cm 3 days after vaccination.
In the event of anaphylactic reaction consult your veterinarian. In such cases
appropriate treatment should be administered without delay.
Sows:
Mean 0.9 °C, with individual animals displaying a temperature increase of above 2 °C.
May be observed 1 to 2 days after vaccination. All animals return to normal within 1 to
3 days after vaccination.
Mostly non-painful swellings < 10 cm in diameter. In some cases, swelling may be
warm, red, and painful > 10 cm in diameter. These reactions disappear or clearly
diminish 14 days after vaccination.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.

Vaccinate healthy animals only.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product.
A decision to use this vaccine before or after any other veterinary medicinal product
therefore needs to be made on a case by case basis.

Store in a refrigerator (2 °C – 8 °C).
Do not freeze.
Protect from light.

Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.